Last reviewed · How we verify
NCT05431790
Absorbable Interface Screw Clinical Trial
NA trial testing Absorbable interface screws manufactured by Natong Biotechnology in Anterior Cruciate Ligament Rupture in 86 participants. Status unknown.
30 May 2023
Quick facts
| Lead sponsor | Peking University Third Hospital |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 86 |
| Start date | 30 July 2022 |
| Primary completion | 30 May 2023 |
| Estimated completion | 30 June 2023 |
Drugs / interventions tested
- Absorbable interface screws manufactured by Natong Biotechnology
- Absorbable interface screws manufactured by INION.
Conditions studied
- Anterior Cruciate Ligament Rupture — all drugs for Anterior Cruciate Ligament Rupture →
Sponsor
Peking University Third Hospital
Who can join
Adults 18 to 80, any sex, with Anterior Cruciate Ligament Rupture. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Validation of the safety and efficacy of absorbable interface screws for clinical use
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05431790
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Anterior Cruciate Ligament Rupture
Currently open trials in the same condition.
- NCT07589582 — Active Noise-Cancelling Headphones Reduce Operative Time and Improve Procedural Consistency in ACL Reconstruction l · NA · active not recruiting
- NCT06357091 — ACL Reconstruction With Shark Screw® or Biocomposite-interference Screws · NA · recruiting
- NCT07333092 — Investigation of the Effects of Proprioceptive Exercises After Anterior Cruciate Ligament Surgery · NA · recruiting
- NCT06955026 — Effect of the Hockey Slideboard Training Combined With Blood Flow Restriction (BFR) in the Rehabilitation Following Ante · NA · recruiting
- NCT05174611 — Vitamin D to Improve Quadricep Muscle Strength · Phase 2 · recruiting
Other Peking University Third Hospital trials
Trials by the same sponsor.
- NCT07532421 — Probiotic Intervention on the Development of Allergic Diseases in Infants Exposed to Antibiotics Early in Life · NA · not yet recruiting
- NCT07470255 — Detection of Diabetic Foot Skin Damage Using Plantar Mechanical Parameters · not yet recruiting
- NCT07453381 — Multisensor Wireless Pressure Microcatheter For Microvascular Function Assessment In ANOCA/INOCA Patients: A Prospective · not yet recruiting
- NCT07452354 — AI-Based Diabetic Foot Recurrence Cohort · not yet recruiting
- NCT07423819 — Sports Rehabilitation Therapy for Knee Joint Sports Injuries: A Case Study of Anterior Cruciate Ligament Injury and Pate · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05431790 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Peking University Third Hospital
- Last refreshed: 24 June 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05431790.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing